Delayed
Canadian Securities Exchange
01:25:34 2022-02-03 pm EST
|
5-day change
|
1st Jan Change
|
0.5
CAD
|
+4.17%
|
|
+21.95%
|
-.--%
|
Fiscal Period: September |
2019
|
2020
|
2021
|
2022
|
---|
Capitalization
1 |
37.95
|
9.564
|
3.415
|
1.138
|
Enterprise Value (EV)
1 |
51.85
|
15.43
|
10.05
|
8.803
|
P/E ratio
|
-0.5
x
|
-0.18
x
|
-0.18
x
|
-0.52
x
|
Yield
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
32,059,455
x
|
3,166,028
x
|
13,643,225
x
|
EV / Revenue
|
-
|
51,722,431
x
|
9,317,089
x
|
105,511,231
x
|
EV / EBITDA
|
-
|
-2,034,351
x
|
-2,727,128
x
|
-
|
EV / FCF
|
7,027,529
x
|
-2,737,615
x
|
-877,361
x
|
-33,014,503
x
|
FCF Yield
|
0%
|
-0%
|
-0%
|
-0%
|
Price to Book
|
4.05
x
|
-1.12
x
|
-0.44
x
|
-0.12
x
|
Nbr of stocks (in thousands)
|
162
|
1,195
|
2,276
|
2,276
|
Reference price
2 |
234.0
|
8.000
|
1.500
|
0.5000
|
Announcement Date
|
1/28/20
|
1/29/21
|
10/5/22
|
4/17/23
|
Fiscal Period: September |
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net sales
|
-
|
-
|
0.2983
|
1.079
|
0.0834
|
EBITDA
|
-
|
-
|
-7.584
|
-3.685
|
-
|
EBIT
1 |
-0.9029
|
-24.42
|
-7.817
|
-3.752
|
-1.126
|
Operating Margin
|
-
|
-
|
-2,620.56%
|
-347.84%
|
-1,349.07%
|
Earnings before Tax (EBT)
1 |
-1.904
|
-54.22
|
-35.59
|
-16.71
|
-2.18
|
Net income
1 |
-1.904
|
-54.22
|
-35.59
|
-16.71
|
-2.18
|
Net margin
|
-
|
-
|
-11,930.2%
|
-1,549.76%
|
-2,612.62%
|
EPS
2 |
-108.2
|
-465.1
|
-44.11
|
-8.217
|
-0.9575
|
Free Cash Flow
|
-
|
7.379
|
-5.636
|
-11.45
|
-0.2666
|
FCF margin
|
-
|
-
|
-1,889.32%
|
-1,061.94%
|
-319.59%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
5/31/19
|
1/28/20
|
1/29/21
|
10/5/22
|
4/17/23
|
Fiscal Period: September |
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net Debt
1 |
-
|
13.9
|
5.87
|
6.63
|
7.66
|
Net Cash position
1 |
0.76
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-0.7734
x
|
-1.8
x
|
-
|
Free Cash Flow
|
-
|
7.38
|
-5.64
|
-11.5
|
-0.27
|
ROE (net income / shareholders' equity)
|
-
|
-799%
|
-9,017%
|
206%
|
24.9%
|
ROA (Net income/ Total Assets)
|
-
|
-73.6%
|
-21.3%
|
-45.6%
|
-148%
|
Assets
1 |
-
|
73.65
|
167.3
|
36.62
|
1.477
|
Book Value Per Share
2 |
116.0
|
57.70
|
-7.170
|
-3.370
|
-4.330
|
Cash Flow per Share
2 |
20.80
|
0.7000
|
0.1600
|
0.0100
|
0.0100
|
Capex
|
-
|
0.06
|
0.08
|
-
|
-
|
Capex / Sales
|
-
|
-
|
27.03%
|
-
|
-
|
Announcement Date
|
5/31/19
|
1/28/20
|
1/29/21
|
10/5/22
|
4/17/23
|
|
1st Jan change
|
Capi.
|
---|
| -.--% | 831K | | +37.08% | 5.92B | | -17.43% | 4.51B | | -9.46% | 3.15B | | +0.51% | 3.1B | | -3.53% | 2.42B | | +41.15% | 1.97B | | -5.15% | 1.68B | | +0.09% | 1.65B | | -10.38% | 1.53B |
Alternative Medicine
|